Related Experiment Video
Updated: Aug 16, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network
Xueqin Sun1, Olaf Klingbeil1, Bin Lu1
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
Abstract:
Inhibition of the tumour suppressive function of p53 (encoded by TP53) is paramount for cancer development in humans. However, p53 remains unmutated in the majority of cases of glioblastoma (GBM)-the most common and deadly adult brain malignancy1,2. Thus, how p53-mediated tumour suppression is countered in TP53 wild-type (TP53WT) GBM is unknown. Here we describe a GBM-specific epigenetic mechanism in which the chromatin regulator bromodomain-containing protein 8 (BRD8) maintains H2AZ occupancy at p53 target loci through the EP400 histone acetyltransferase complex. This mechanism causes a repressive chromatin state that prevents transactivation by p53 and sustains proliferation. Notably, targeting the bromodomain of BRD8 displaces H2AZ, enhances chromatin accessibility and engages p53 transactivation. This in turn enforces cell cycle arrest and tumour suppression in TP53WT GBM. In line with these findings, BRD8 is highly expressed with H2AZ in proliferating single cells of patient-derived GBM, and is inversely correlated with CDKN1A, a canonical p53 target that encodes p21 (refs. 3,4). This work identifies BRD8 as a selective epigenetic vulnerability for a malignancy for which treatment has not improved for decades. Moreover, targeting the bromodomain of BRD8 may be a promising therapeutic strategy for patients with TP53WT GBM.
Insights
A novel epigenetic mechanism in glioblastoma (GBM) involves BRD8 maintaining a repressive chromatin state, hindering p53
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- p53 (TP53) tumor suppressor function is crucial in human cancers.
- p53 is frequently unmutated in glioblastoma (GBM), the deadliest adult brain cancer.
- The mechanism countering p53 in wild-type GBM (TP53WT) is largely unknown.
Purpose of the Study:
- To elucidate the epigenetic mechanisms counteracting p53 in TP53WT GBM.
- To identify potential therapeutic targets for TP53WT GBM.
Main Methods:
- Investigated the role of bromodomain-containing protein 8 (BRD8) in GBM.
- Analyzed chromatin states, H2AZ occupancy, and p53 target gene transactivation.
- Examined BRD8 and H2AZ expression in patient-derived GBM cells.
Main Results:
- BRD8, via the EP400 complex, maintains H2AZ at p53 target loci, creating repressive chromatin.
- This epigenetic state prevents p53 transactivation and promotes GBM cell proliferation.
- Targeting BRD8's bromodomain displaces H2AZ, enhances chromatin accessibility, and restores p53 activity, inducing cell cycle arrest and tumor suppression.
- BRD8 and H2AZ are highly expressed in proliferating GBM cells, inversely correlated with p53 target CDKN1A (p21).
Conclusions:
- BRD8 is a key epigenetic regulator that suppresses p53 function in TP53WT GBM.
- BRD8 represents a selective epigenetic vulnerability in GBM.
- Targeting the BRD8 bromodomain offers a potential therapeutic strategy for TP53WT GBM.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Epigenetic Regulation
X-chromosome...
Mitogens and the Cell Cycle